These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26982196)

  • 21. Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test.
    Pane M; Fanelli L; Mazzone ES; Olivieri G; D'Amico A; Messina S; Scutifero M; Battini R; Petillo R; Frosini S; Sivo S; Vita GL; Bruno C; Mongini T; Pegoraro E; De Sanctis R; Gardani A; Berardinelli A; Lanzillotta V; Carlesi A; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Bianco F; Bonfiglio S; Rolle E; Palermo C; D'Angelo G; Pini A; Iotti E; Gorni K; Baranello G; Bertini E; Politano L; Sormani MP; Mercuri E
    Neuromuscul Disord; 2015 Oct; 25(10):749-53. PubMed ID: 26248957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticosteroids for the treatment of Duchenne muscular dystrophy.
    Matthews E; Brassington R; Kuntzer T; Jichi F; Manzur AY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003725. PubMed ID: 27149418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.
    Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K
    Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can simple and low-cost motor function assessments help in the diagnostic suspicion of Duchenne muscular dystrophy?
    Pereira AC; Araújo APQC; Ribeiro MG
    J Pediatr (Rio J); 2020; 96(4):503-510. PubMed ID: 31009620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids.
    Goemans N; van den Hauwe M; Wilson R; van Impe A; Klingels K; Buyse G
    Neuromuscul Disord; 2013 Aug; 23(8):618-23. PubMed ID: 23770101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cessation of ambulation results in a dramatic loss of trabecular bone density in boys with Duchenne muscular dystrophy (DMD).
    Crabtree NJ; Roper H; Shaw NJ
    Bone; 2022 Jan; 154():116248. PubMed ID: 34718220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial.
    Seferian AM; Moraux A; Annoussamy M; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Mayer M; Maincent K; Desguerre I; Thémar-Noël C; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
    PLoS One; 2015; 10(2):e0113999. PubMed ID: 25643053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial.
    Schiava M; McDermott MP; Broomfield J; Abrams KR; Mayhew AG; McDonald CM; Martens WB; Gregory SJ; Griggs RC; Guglieri M;
    Neurology; 2024 May; 102(10):e209206. PubMed ID: 38710006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Mercuri E; Vilchez JJ; Boespflug-Tanguy O; Zaidman CM; Mah JK; Goemans N; Müller-Felber W; Niks EH; Schara-Schmidt U; Bertini E; Comi GP; Mathews KD; Servais L; Vandenborne K; Johannsen J; Messina S; Spinty S; McAdam L; Selby K; Byrne B; Laverty CG; Carroll K; Zardi G; Cazzaniga S; Coceani N; Bettica P; McDonald CM;
    Lancet Neurol; 2024 Apr; 23(4):393-403. PubMed ID: 38508835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing electrical impedance myography measurements by using a multifrequency ratio: a study in Duchenne muscular dystrophy.
    Schwartz S; Geisbush TR; Mijailovic A; Pasternak A; Darras BT; Rutkove SB
    Clin Neurophysiol; 2015 Jan; 126(1):202-8. PubMed ID: 24929900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI Assessment of Motor Capabilities in Patients with Duchenne Muscular Dystrophy According to the Motor Function Measure Scale.
    Suslov V; Suslova G; Lytaev S
    Tomography; 2022 Apr; 8(2):948-960. PubMed ID: 35448710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients.
    Beenakker EA; Maurits NM; Fock JM; Brouwer OF; van der Hoeven JH
    Eur J Paediatr Neurol; 2005; 9(6):387-93. PubMed ID: 16102988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
    Bourke JP; Bueser T; Quinlivan R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study.
    McDonald CM; Henricson EK; Abresch RT; Florence JM; Eagle M; Gappmaier E; Glanzman AM; ; Spiegel R; Barth J; Elfring G; Reha A; Peltz S
    Muscle Nerve; 2013 Sep; 48(3):343-56. PubMed ID: 23681930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.
    McDonald CM; Henricson EK; Abresch RT; Florence J; Eagle M; Gappmaier E; Glanzman AM; ; Spiegel R; Barth J; Elfring G; Reha A; Peltz SW
    Muscle Nerve; 2013 Sep; 48(3):357-68. PubMed ID: 23674289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy.
    Yin L; Xie ZY; Xu HY; Zheng SS; Wang ZX; Xiao JX; Yuan Y
    Curr Med Sci; 2019 Feb; 39(1):138-145. PubMed ID: 30868504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy.
    Wary C; Azzabou N; Giraudeau C; Le Louër J; Montus M; Voit T; Servais L; Carlier P
    NMR Biomed; 2015 Sep; 28(9):1150-62. PubMed ID: 26215733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy.
    Pane M; Mazzone ES; Fanelli L; De Sanctis R; Bianco F; Sivo S; D'Amico A; Messina S; Battini R; Scutifero M; Petillo R; Frosini S; Scalise R; Vita G; Bruno C; Pedemonte M; Mongini T; Pegoraro E; Brustia F; Gardani A; Berardinelli A; Lanzillotta V; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Bonfiglio S; Rolle E; Colia G; Catteruccia M; Palermo C; D'Angelo G; Pini A; Iotti E; Gorni K; Baranello G; Morandi L; Bertini E; Politano L; Sormani M; Mercuri E
    Neuromuscul Disord; 2014 Mar; 24(3):201-6. PubMed ID: 24440357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study.
    Coratti G; Pane M; Brogna C; D'Amico A; Pegoraro E; Bello L; Sansone VA; Albamonte E; Ferraroli E; Mazzone ES; Fanelli L; Messina S; Sframeli M; Catteruccia M; Cicala G; Capasso A; Ricci M; Frosini S; De Luca G; Rolle E; De Sanctis R; Forcina N; Norcia G; Passamano L; Scutifero M; Gardani A; Pini A; Monaco G; D'Angelo MG; Leone D; Zanin R; Vita GL; Panicucci C; Bruno C; Mongini T; Ricci F; Berardinelli A; Battini R; Masson R; Baranello G; Dosi C; Bertini E; Nigro V; Politano L; Mercuri E
    Neuromuscul Disord; 2024 Jan; 34():75-82. PubMed ID: 38157655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.
    Mendell JR; Goemans N; Lowes LP; Alfano LN; Berry K; Shao J; Kaye EM; Mercuri E;
    Ann Neurol; 2016 Feb; 79(2):257-71. PubMed ID: 26573217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.